Earnings Feed
Start Free
Talon Therapeutics, Inc.·4

Jul 18, 4:48 PM ET

Talon Therapeutics, Inc. 4

4 · Talon Therapeutics, Inc. · Filed Jul 18, 2013

Insider Transaction Report

Form 4
Period: 2013-07-17
Talon Therapeutics, Inc.TLON
Rosenberg Leon E
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−7,050→ 0 total
    Exercise: $6.74Exp: 2014-02-01→ Common Stock (7,050 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−5,000→ 0 total
    Exercise: $5.32Exp: 2015-04-11→ Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−10,000→ 0 total
    Exercise: $27.28Exp: 2016-12-12→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−10,000→ 0 total
    Exercise: $19.00Exp: 2015-11-10→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−8,750→ 0 total
    Exercise: $8.16Exp: 2017-04-18→ Common Stock (8,750 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−18,750→ 0 total
    Exercise: $4.48Exp: 2017-12-14→ Common Stock (18,750 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−18,750→ 0 total
    Exercise: $0.56Exp: 2019-02-24→ Common Stock (18,750 underlying)
  • Disposition to Issuer

    Common Stock

    2013-07-17−250→ 250 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−18,750→ 0 total
    Exercise: $0.76Exp: 2020-02-16→ Common Stock (18,750 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−65,000→ 0 total
    Exercise: $0.91Exp: 2022-02-17→ Common Stock (65,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−5,000→ 0 total
    Exercise: $6.60Exp: 2015-07-14→ Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−65,000→ 0 total
    Exercise: $0.77Exp: 2021-04-01→ Common Stock (65,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-07-17−65,000→ 0 total
    Exercise: $0.64Exp: 2023-01-25→ Common Stock (65,000 underlying)
Footnotes (2)
  • [F1]The reporting person received $0.056 per share plus one contingent value right (CVR) per share in accordance with the terms of a Stock Purchase Agreement by and among Talon Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Eagle Acquisition Merger Sub, Inc. dated July 16, 2013 (the "Purchase Agreement"). Each CVR represents the right to receive a maximum future cash payment of approximately $0.968 per CVR from Spectrum based upon the achievement of certain sales and regulatory milestones.
  • [F2]This stock option was cancelled pursuant to the terms of the Purchase Agreement.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT